Prenatal cannabinoid exposure altered reproductive cell development differently in male and female offspring
In an animal model, prenatal exposure to a CB2 receptor agonist produced sex-specific changes in offspring germ cells through histone modifications, suggesting cannabinoid exposure during pregnancy may affect reproductive development.
Quick Facts
What This Study Found
Prenatal CB2 receptor activation caused sex-specific changes in germ cell development in offspring, with effects mediated through histone modifications (epigenetic changes). Male and female germ cells were affected differently.
Key Numbers
Prenatal CB2 agonist exposure. Sex-specific effects on germ cells. Histone modification changes identified in offspring reproductive cells.
How They Did This
Animal study exposing pregnant animals to a CB2 receptor agonist. Examined effects on male and female offspring germ cells using epigenetic (histone modification) analysis.
Why This Research Matters
Cannabis use during pregnancy is increasing, and potential effects on offspring reproductive development are poorly understood. This study identifies a specific mechanism (epigenetic changes in germ cells) through which prenatal cannabinoid exposure could affect fertility in the next generation.
The Bigger Picture
Epigenetic effects of prenatal exposures can potentially extend across generations. If cannabinoid exposure during pregnancy alters germ cells in offspring, it could theoretically affect the fertility and health of grandchildren.
What This Study Doesn't Tell Us
Animal study using a specific CB2 agonist, not whole cannabis. Doses may not reflect human exposure levels. Germ cell changes may not translate to functional fertility effects. Sex-specific effects need replication. Transgenerational implications are speculative.
Questions This Raises
- ?Do these epigenetic changes in germ cells persist into adulthood?
- ?Would they affect actual fertility or offspring health in the next generation?
Trust & Context
- Key Stat:
- Prenatal CB2 activation caused sex-specific germ cell changes via histone modification
- Evidence Grade:
- Animal study identifying an epigenetic mechanism. Important signal but distant from human clinical relevance.
- Study Age:
- Published 2023.
- Original Title:
- Prenatal exposure to CB2 receptors agonist differentially impacts male and female germ cells via histone modification.
- Published In:
- Mechanisms of ageing and development, 213, 111840 (2023)
- Authors:
- Zucchi, Alice, Innocenzi, Elisa(2), Onorato, Angelo, Dolci, Susanna, Colopi, Ambra, Balistreri, Carmela Rita, Grimaldi, Paola
- Database ID:
- RTHC-05057
Evidence Hierarchy
Frequently Asked Questions
Can cannabis use during pregnancy affect children's fertility?
This animal study found that activating cannabinoid receptors during pregnancy changed the development of reproductive cells in offspring. Whether this translates to human fertility effects is unknown. The finding raises a theoretical concern that needs human research to evaluate.
What are histone modifications?
Histones are proteins around which DNA wraps. Chemical modifications to histones (like methylation or acetylation) change which genes are turned on or off without changing the DNA sequence itself. This type of epigenetic change can be passed to daughter cells and potentially to future generations.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-05057APA
Zucchi, Alice; Innocenzi, Elisa; Onorato, Angelo; Dolci, Susanna; Colopi, Ambra; Balistreri, Carmela Rita; Grimaldi, Paola. (2023). Prenatal exposure to CB2 receptors agonist differentially impacts male and female germ cells via histone modification.. Mechanisms of ageing and development, 213, 111840. https://doi.org/10.1016/j.mad.2023.111840
MLA
Zucchi, Alice, et al. "Prenatal exposure to CB2 receptors agonist differentially impacts male and female germ cells via histone modification.." Mechanisms of ageing and development, 2023. https://doi.org/10.1016/j.mad.2023.111840
RethinkTHC
RethinkTHC Research Database. "Prenatal exposure to CB2 receptors agonist differentially im..." RTHC-05057. Retrieved from https://rethinkthc.com/research/zucchi-2023-prenatal-exposure-to-cb2
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.